 | • レポートコード：QAF27622 • 出版社/出版日：QYResearch / 2021年4月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界の臨床質量分析市場について種類別（LC-MS、GC-MS、その他）、用途別（臨床診断、臨床研究）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・臨床質量分析市場の概要 ・世界の主要地域別臨床質量分析市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界の臨床質量分析市場規模2016-2021：種類別（LC-MS、GC-MS、その他） ・世界の臨床質量分析市場予測2012-2027：種類別（LC-MS、GC-MS、その他） ・世界の臨床質量分析市場規模2016-2021：用途別（臨床診断、臨床研究） ・世界の臨床質量分析市場予測2012-2027：用途別（臨床診断、臨床研究） ・臨床質量分析のアメリカ市場規模と予測2016-2021 ・臨床質量分析のヨーロッパ市場規模と予測2016-2021 ・臨床質量分析の中国市場規模と予測2016-2021 ・臨床質量分析の日本市場規模と予測2016-2021 ・臨床質量分析の東南アジア市場規模と予測2016-2021 ・臨床質量分析のインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （AB Sciex (Danaher)、Bruker、Thermo Fisher、Agilent、Waters、Perkin Elmer、Shidmazu） ・臨床質量分析の製造コスト分析 ・販売チャネル、流通業者、顧客 ・臨床質量分析の市場動向・機会・課題 ・調査の結論 |
Mass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant improvements in assay performance are occurring rapidly in areas such as toxicology, endocrinology, and biochemical genetics.
Clinical mass spectrometry uses the mass spectrometry technology for diagnostic purposes. Employed by medical labs, clinical mass spectrometry is used to diagnose metabolism deficiencies, to determine whether biomarkers or enzymes are present, and for toxicology testing.
The global production of the Clinical Mass Spectrometry is about 1931 units, North America is the largest production region, and the North America occupies about 63% of the market share. The second largest region is Europe, the region occupies about 25% market share, the Asia has little production, it only occupies about 10% market share in 2015. The largest company is Thermo Fisher, it occupies more than 26% of the market share, and the second largest company is AB Sciex (Danaher).
Market Analysis and Insights: Global Clinical Mass Spectrometry Market
The global Clinical Mass Spectrometry market was valued at US$ 968.8 in 2020 and will reach US$ 1725.7 million by the end of 2027, growing at a CAGR of 10.1% during 2022-2027.
Global Clinical Mass Spectrometry Scope and Market Size
The global Clinical Mass Spectrometry market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Clinical Mass Spectrometry market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
LC-MS
GC-MS
Others
Segment by Application
Clinical Diagnostics
Clinical Research
The Clinical Mass Spectrometry market is analysed and market size information is provided by regions (countries). Segment by Application, the Clinical Mass Spectrometry market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
AB Sciex (Danaher)
Bruker
Thermo Fisher
Agilent
Waters
Perkin Elmer
Shidmazu
1 Clinical Mass Spectrometry Market Overview
1.1 Clinical Mass Spectrometry Product Scope
1.2 Clinical Mass Spectrometry Segment by Type
1.2.1 Global Clinical Mass Spectrometry Sales by Type (2016 & 2021 & 2027)
1.2.2 LC-MS
1.2.3 GC-MS
1.2.4 Others
1.3 Clinical Mass Spectrometry Segment by Application
1.3.1 Global Clinical Mass Spectrometry Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Clinical Diagnostics
1.3.3 Clinical Research
1.4 Clinical Mass Spectrometry Market Estimates and Forecasts (2016-2027)
1.4.1 Global Clinical Mass Spectrometry Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Clinical Mass Spectrometry Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Clinical Mass Spectrometry Price Trends (2016-2027)
2 Clinical Mass Spectrometry Estimates and Forecasts by Region
2.1 Global Clinical Mass Spectrometry Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Clinical Mass Spectrometry Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Clinical Mass Spectrometry Sales Market Share by Region (2016-2021)
2.2.2 Global Clinical Mass Spectrometry Revenue Market Share by Region (2016-2021)
2.3 Global Clinical Mass Spectrometry Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Clinical Mass Spectrometry Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Clinical Mass Spectrometry Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Clinical Mass Spectrometry Estimates and Projections (2016-2027)
2.4.2 Europe Clinical Mass Spectrometry Estimates and Projections (2016-2027)
2.4.3 China Clinical Mass Spectrometry Estimates and Projections (2016-2027)
2.4.4 Japan Clinical Mass Spectrometry Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Clinical Mass Spectrometry Estimates and Projections (2016-2027)
2.4.6 India Clinical Mass Spectrometry Estimates and Projections (2016-2027)
3 Global Clinical Mass Spectrometry Competition Landscape by Players
3.1 Global Top Clinical Mass Spectrometry Players by Sales (2016-2021)
3.2 Global Top Clinical Mass Spectrometry Players by Revenue (2016-2021)
3.3 Global Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Clinical Mass Spectrometry as of 2020)
3.4 Global Clinical Mass Spectrometry Average Price by Company (2016-2021)
3.5 Manufacturers Clinical Mass Spectrometry Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Clinical Mass Spectrometry Market Size by Type
4.1 Global Clinical Mass Spectrometry Historic Market Review by Type (2016-2021)
4.1.1 Global Clinical Mass Spectrometry Sales Market Share by Type (2016-2021)
4.1.2 Global Clinical Mass Spectrometry Revenue Market Share by Type (2016-2021)
4.1.3 Global Clinical Mass Spectrometry Price by Type (2016-2021)
4.2 Global Clinical Mass Spectrometry Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Clinical Mass Spectrometry Sales Forecast by Type (2022-2027)
4.2.2 Global Clinical Mass Spectrometry Revenue Forecast by Type (2022-2027)
4.2.3 Global Clinical Mass Spectrometry Price Forecast by Type (2022-2027)
5 Global Clinical Mass Spectrometry Market Size by Application
5.1 Global Clinical Mass Spectrometry Historic Market Review by Application (2016-2021)
5.1.1 Global Clinical Mass Spectrometry Sales Market Share by Application (2016-2021)
5.1.2 Global Clinical Mass Spectrometry Revenue Market Share by Application (2016-2021)
5.1.3 Global Clinical Mass Spectrometry Price by Application (2016-2021)
5.2 Global Clinical Mass Spectrometry Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Clinical Mass Spectrometry Sales Forecast by Application (2022-2027)
5.2.2 Global Clinical Mass Spectrometry Revenue Forecast by Application (2022-2027)
5.2.3 Global Clinical Mass Spectrometry Price Forecast by Application (2022-2027)
6 North America Clinical Mass Spectrometry Market Facts & Figures
6.1 North America Clinical Mass Spectrometry Sales by Company
6.1.1 North America Clinical Mass Spectrometry Sales by Company (2016-2021)
6.1.2 North America Clinical Mass Spectrometry Revenue by Company (2016-2021)
6.2 North America Clinical Mass Spectrometry Sales Breakdown by Type
6.2.1 North America Clinical Mass Spectrometry Sales Breakdown by Type (2016-2021)
6.2.2 North America Clinical Mass Spectrometry Sales Breakdown by Type (2022-2027)
6.3 North America Clinical Mass Spectrometry Sales Breakdown by Application
6.3.1 North America Clinical Mass Spectrometry Sales Breakdown by Application (2016-2021)
6.3.2 North America Clinical Mass Spectrometry Sales Breakdown by Application (2022-2027)
7 Europe Clinical Mass Spectrometry Market Facts & Figures
7.1 Europe Clinical Mass Spectrometry Sales by Company
7.1.1 Europe Clinical Mass Spectrometry Sales by Company (2016-2021)
7.1.2 Europe Clinical Mass Spectrometry Revenue by Company (2016-2021)
7.2 Europe Clinical Mass Spectrometry Sales Breakdown by Type
7.2.1 Europe Clinical Mass Spectrometry Sales Breakdown by Type (2016-2021)
7.2.2 Europe Clinical Mass Spectrometry Sales Breakdown by Type (2022-2027)
7.3 Europe Clinical Mass Spectrometry Sales Breakdown by Application
7.3.1 Europe 136 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 136 Sales Breakdown by Application (2022-2027)
8 China Clinical Mass Spectrometry Market Facts & Figures
8.1 China Clinical Mass Spectrometry Sales by Company
8.1.1 China Clinical Mass Spectrometry Sales by Company (2016-2021)
8.1.2 China Clinical Mass Spectrometry Revenue by Company (2016-2021)
8.2 China Clinical Mass Spectrometry Sales Breakdown by Type
8.2.1 China Clinical Mass Spectrometry Sales Breakdown by Type (2016-2021)
8.2.2 China Clinical Mass Spectrometry Sales Breakdown by Type (2022-2027)
8.3 China Clinical Mass Spectrometry Sales Breakdown by Application
8.3.1 China 243 Sales Breakdown by Application (2016-2021)
8.3.2 China 243 Sales Breakdown by Application (2022-2027)
9 Japan Clinical Mass Spectrometry Market Facts & Figures
9.1 Japan Clinical Mass Spectrometry Sales by Company
9.1.1 Japan Clinical Mass Spectrometry Sales by Company (2016-2021)
9.1.2 Japan Clinical Mass Spectrometry Revenue by Company (2016-2021)
9.2 Japan Clinical Mass Spectrometry Sales Breakdown by Type
9.2.1 Japan Clinical Mass Spectrometry Sales Breakdown by Type (2016-2021)
9.2.2 Japan Clinical Mass Spectrometry Sales Breakdown by Type (2022-2027)
9.3 Japan Clinical Mass Spectrometry Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Clinical Mass Spectrometry Market Facts & Figures
10.1 Southeast Asia Clinical Mass Spectrometry Sales by Company
10.1.1 Southeast Asia Clinical Mass Spectrometry Sales by Company (2016-2021)
10.1.2 Southeast Asia Clinical Mass Spectrometry Revenue by Company (2016-2021)
10.2 Southeast Asia Clinical Mass Spectrometry Sales Breakdown by Type
10.2.1 Southeast Asia Clinical Mass Spectrometry Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Clinical Mass Spectrometry Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Clinical Mass Spectrometry Sales Breakdown by Application
10.3.1 Southeast Asia Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Units Sales Breakdown by Application (2022-2027)
11 India Clinical Mass Spectrometry Market Facts & Figures
11.1 India Clinical Mass Spectrometry Sales by Company
11.1.1 India Clinical Mass Spectrometry Sales by Company (2016-2021)
11.1.2 India Clinical Mass Spectrometry Revenue by Company (2016-2021)
11.2 India Clinical Mass Spectrometry Sales Breakdown by Type
11.2.1 India Clinical Mass Spectrometry Sales Breakdown by Type (2016-2021)
11.2.2 India Clinical Mass Spectrometry Sales Breakdown by Type (2022-2027)
11.3 India Clinical Mass Spectrometry Sales Breakdown by Application
11.3.1 India Clinical Mass Spectrometry Sales Breakdown by Application (2016-2021)
11.3.2 India Clinical Mass Spectrometry Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Clinical Mass Spectrometry Business
12.1 AB Sciex (Danaher)
12.1.1 AB Sciex (Danaher) Corporation Information
12.1.2 AB Sciex (Danaher) Business Overview
12.1.3 AB Sciex (Danaher) Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AB Sciex (Danaher) Clinical Mass Spectrometry Products Offered
12.1.5 AB Sciex (Danaher) Recent Development
12.2 Bruker
12.2.1 Bruker Corporation Information
12.2.2 Bruker Business Overview
12.2.3 Bruker Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bruker Clinical Mass Spectrometry Products Offered
12.2.5 Bruker Recent Development
12.3 Thermo Fisher
12.3.1 Thermo Fisher Corporation Information
12.3.2 Thermo Fisher Business Overview
12.3.3 Thermo Fisher Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Thermo Fisher Clinical Mass Spectrometry Products Offered
12.3.5 Thermo Fisher Recent Development
12.4 Agilent
12.4.1 Agilent Corporation Information
12.4.2 Agilent Business Overview
12.4.3 Agilent Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Agilent Clinical Mass Spectrometry Products Offered
12.4.5 Agilent Recent Development
12.5 Waters
12.5.1 Waters Corporation Information
12.5.2 Waters Business Overview
12.5.3 Waters Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Waters Clinical Mass Spectrometry Products Offered
12.5.5 Waters Recent Development
12.6 Perkin Elmer
12.6.1 Perkin Elmer Corporation Information
12.6.2 Perkin Elmer Business Overview
12.6.3 Perkin Elmer Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Perkin Elmer Clinical Mass Spectrometry Products Offered
12.6.5 Perkin Elmer Recent Development
12.7 Shidmazu
12.7.1 Shidmazu Corporation Information
12.7.2 Shidmazu Business Overview
12.7.3 Shidmazu Clinical Mass Spectrometry Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Shidmazu Clinical Mass Spectrometry Products Offered
12.7.5 Shidmazu Recent Development
…
13 Clinical Mass Spectrometry Manufacturing Cost Analysis
13.1 Clinical Mass Spectrometry Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Clinical Mass Spectrometry
13.4 Clinical Mass Spectrometry Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Clinical Mass Spectrometry Distributors List
14.3 Clinical Mass Spectrometry Customers
15 Market Dynamics
15.1 Clinical Mass Spectrometry Market Trends
15.2 Clinical Mass Spectrometry Drivers
15.3 Clinical Mass Spectrometry Market Challenges
15.4 Clinical Mass Spectrometry Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Clinical Mass Spectrometry Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Clinical Mass Spectrometry Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Clinical Mass Spectrometry Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Clinical Mass Spectrometry Sales (Units) by Region (2016-2021)
Table 5. Global Clinical Mass Spectrometry Sales Market Share by Region (2016-2021)
Table 6. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Clinical Mass Spectrometry Revenue Share by Region (2016-2021)
Table 8. Global Clinical Mass Spectrometry Sales (Units) Forecast by Region (2022-2027)
Table 9. Global Clinical Mass Spectrometry Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Clinical Mass Spectrometry Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Clinical Mass Spectrometry Revenue Share Forecast by Region (2022-2027)
Table 12. Global Clinical Mass Spectrometry Sales (Units) of Key Companies (2016-2021)
Table 13. Global Clinical Mass Spectrometry Sales Share by Company (2016-2021)
Table 14. Global Clinical Mass Spectrometry Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Clinical Mass Spectrometry Revenue Share by Company (2016-2021)
Table 16. Global Clinical Mass Spectrometry by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Clinical Mass Spectrometry as of 2020)
Table 17. Global Clinical Mass Spectrometry Average Price (K USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Clinical Mass Spectrometry Manufacturing Sites and Area Served
Table 19. Manufacturers Clinical Mass Spectrometry Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Clinical Mass Spectrometry Sales (Units) by Type (2016-2021)
Table 22. Global Clinical Mass Spectrometry Sales Share by Type (2016-2021)
Table 23. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Clinical Mass Spectrometry Price (K USD/Unit) by Type (2016-2021)
Table 25. Global Clinical Mass Spectrometry Sales Share by Type (2022-2027)
Table 26. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Clinical Mass Spectrometry Revenue Share by Type (2022-2027)
Table 28. Global Clinical Mass Spectrometry Price (K USD/Unit) by Type (2022-2027)
Table 29. Global Clinical Mass Spectrometry Sales (Units) by Application (2016-2021)
Table 30. Global Clinical Mass Spectrometry Sales Share by Application (2016-2021)
Table 31. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Clinical Mass Spectrometry Price (K USD/Unit) by Application (2016-2021)
Table 33. Global Clinical Mass Spectrometry Sales (Units) by Application (2022-2027)
Table 34. Global Clinical Mass Spectrometry Sales Share by Application (2022-2027)
Table 35. Global Clinical Mass Spectrometry Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Clinical Mass Spectrometry Revenue Share by Application (2022-2027)
Table 37. Global Clinical Mass Spectrometry Price (K USD/Unit) by Application (2022-2027)
Table 38. North America Clinical Mass Spectrometry Sales (Units) by Company (2016-2021)
Table 39. North America Clinical Mass Spectrometry Sales Market Share by Company (2016-2021)
Table 40. North America Clinical Mass Spectrometry Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Clinical Mass Spectrometry Revenue Market Share by Company (2016-2021)
Table 42. North America Clinical Mass Spectrometry Sales by Type (2016-2021) & (Units)
Table 43. North America Clinical Mass Spectrometry Sales Market Share by Type (2016-2021)
Table 44. North America Clinical Mass Spectrometry Sales by Type (2022-2027) & (Units)
Table 45. North America Clinical Mass Spectrometry Sales Market Share by Type (2022-2027)
Table 46. North America Clinical Mass Spectrometry Sales by Application (2016-2021) & (Units)
Table 47. North America Clinical Mass Spectrometry Sales Market Share by Application (2016-2021)
Table 48. North America Clinical Mass Spectrometry Sales by Application (2022-2027) & (Units)
Table 49. North America Clinical Mass Spectrometry Sales Market Share by Application (2022-2027)
Table 50. Europe Clinical Mass Spectrometry Sales (Units) by Company (2016-2021)
Table 51. Europe Clinical Mass Spectrometry Sales Market Share by Company (2016-2021)
Table 52. Europe Clinical Mass Spectrometry Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Clinical Mass Spectrometry Revenue Market Share by Company (2016-2021)
Table 54. Europe Clinical Mass Spectrometry Sales by Type (2016-2021) & (Units)
Table 55. Europe Clinical Mass Spectrometry Sales Market Share by Type (2016-2021)
Table 56. Europe Clinical Mass Spectrometry Sales by Type (2022-2027) & (Units)
Table 57. Europe Clinical Mass Spectrometry Sales Market Share by Type (2022-2027)
Table 58. Europe Clinical Mass Spectrometry Sales by Application (2016-2021) & (Units)
Table 59. Europe Clinical Mass Spectrometry Sales Market Share by Application (2016-2021)
Table 60. Europe Clinical Mass Spectrometry Sales by Application (2022-2027) & (Units)
Table 61. Europe Clinical Mass Spectrometry Sales Market Share by Application (2022-2027)
Table 62. China Clinical Mass Spectrometry Sales (Units) by Company (2016-2021)
Table 63. China Clinical Mass Spectrometry Sales Market Share by Company (2016-2021)
Table 64. China Clinical Mass Spectrometry Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Clinical Mass Spectrometry Revenue Market Share by Company (2016-2021)
Table 66. China Clinical Mass Spectrometry Sales by Type (2016-2021) & (Units)
Table 67. China Clinical Mass Spectrometry Sales Market Share by Type (2016-2021)
Table 68. China Clinical Mass Spectrometry Sales by Type (2022-2027) & (Units)
Table 69. China Clinical Mass Spectrometry Sales Market Share by Type (2022-2027)
Table 70. China Clinical Mass Spectrometry Sales by Application (2016-2021) & (Units)
Table 71. China Clinical Mass Spectrometry Sales Market Share by Application (2016-2021)
Table 72. China Clinical Mass Spectrometry Sales by Application (2022-2027) & (Units)
Table 73. China Clinical Mass Spectrometry Sales Market Share by Application (2022-2027)
Table 74. Japan Clinical Mass Spectrometry Sales (Units) by Company (2016-2021)
Table 75. Japan Clinical Mass Spectrometry Sales Market Share by Company (2016-2021)
Table 76. Japan Clinical Mass Spectrometry Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Clinical Mass Spectrometry Revenue Market Share by Company (2016-2021)
Table 78. Japan Clinical Mass Spectrometry Sales by Type (2016-2021) & (Units)
Table 79. Japan Clinical Mass Spectrometry Sales Market Share by Type (2016-2021)
Table 80. Japan Clinical Mass Spectrometry Sales by Type (2022-2027) & (Units)
Table 81. Japan Clinical Mass Spectrometry Sales Market Share by Type (2022-2027)
Table 82. Japan Clinical Mass Spectrometry Sales by Application (2016-2021) & (Units)
Table 83. Japan Clinical Mass Spectrometry Sales Market Share by Application (2016-2021)
Table 84. Japan Clinical Mass Spectrometry Sales by Application (2022-2027) & (Units)
Table 85. Japan Clinical Mass Spectrometry Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Clinical Mass Spectrometry Sales (Units) by Company (2016-2021)
Table 87. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Clinical Mass Spectrometry Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Clinical Mass Spectrometry Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Clinical Mass Spectrometry Sales by Type (2016-2021) & (Units)
Table 91. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Clinical Mass Spectrometry Sales by Type (2022-2027) & (Units)
Table 93. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Clinical Mass Spectrometry Sales by Application (2016-2021) & (Units)
Table 95. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Clinical Mass Spectrometry Sales by Application (2022-2027) & (Units)
Table 97. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Application (2022-2027)
Table 98. India Clinical Mass Spectrometry Sales (Units) by Company (2016-2021)
Table 99. India Clinical Mass Spectrometry Sales Market Share by Company (2016-2021)
Table 100. India Clinical Mass Spectrometry Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Clinical Mass Spectrometry Revenue Market Share by Company (2016-2021)
Table 102. India Clinical Mass Spectrometry Sales by Type (2016-2021) & (Units)
Table 103. India Clinical Mass Spectrometry Sales Market Share by Type (2016-2021)
Table 104. India Clinical Mass Spectrometry Sales by Type (2022-2027) & (Units)
Table 105. India Clinical Mass Spectrometry Sales Market Share by Type (2022-2027)
Table 106. India Clinical Mass Spectrometry Sales by Application (2016-2021) & (Units)
Table 107. India Clinical Mass Spectrometry Sales Market Share by Application (2016-2021)
Table 108. India Clinical Mass Spectrometry Sales by Application (2022-2027) & (Units)
Table 109. India Clinical Mass Spectrometry Sales Market Share by Application (2022-2027)
Table 110. AB Sciex (Danaher) Corporation Information
Table 111. AB Sciex (Danaher) Description and Business Overview
Table 112. AB Sciex (Danaher) Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 113. AB Sciex (Danaher) Clinical Mass Spectrometry Product
Table 114. AB Sciex (Danaher) Recent Development
Table 115. Bruker Corporation Information
Table 116. Bruker Description and Business Overview
Table 117. Bruker Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 118. Bruker Clinical Mass Spectrometry Product
Table 119. Bruker Recent Development
Table 120. Thermo Fisher Corporation Information
Table 121. Thermo Fisher Description and Business Overview
Table 122. Thermo Fisher Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 123. Thermo Fisher Clinical Mass Spectrometry Product
Table 124. Thermo Fisher Recent Development
Table 125. Agilent Corporation Information
Table 126. Agilent Description and Business Overview
Table 127. Agilent Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 128. Agilent Clinical Mass Spectrometry Product
Table 129. Agilent Recent Development
Table 130. Waters Corporation Information
Table 131. Waters Description and Business Overview
Table 132. Waters Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 133. Waters Clinical Mass Spectrometry Product
Table 134. Waters Recent Development
Table 135. Perkin Elmer Corporation Information
Table 136. Perkin Elmer Description and Business Overview
Table 137. Perkin Elmer Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 138. Perkin Elmer Clinical Mass Spectrometry Product
Table 139. Perkin Elmer Recent Development
Table 140. Shidmazu Corporation Information
Table 141. Shidmazu Description and Business Overview
Table 142. Shidmazu Clinical Mass Spectrometry Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2016-2021)
Table 143. Shidmazu Clinical Mass Spectrometry Product
Table 144. Shidmazu Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Clinical Mass Spectrometry Distributors List
Table 148. Clinical Mass Spectrometry Customers List
Table 149. Clinical Mass Spectrometry Market Trends
Table 150. Clinical Mass Spectrometry Market Drivers
Table 151. Clinical Mass Spectrometry Market Challenges
Table 152. Clinical Mass Spectrometry Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Clinical Mass Spectrometry Product Picture
Figure 2. Global Clinical Mass Spectrometry Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Clinical Mass Spectrometry Sales Market Share by Application in 2021 & 2027
Figure 6. Clinical Diagnostics Examples
Figure 7. Clinical Research Examples
Figure 8. Global Clinical Mass Spectrometry Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Clinical Mass Spectrometry Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Clinical Mass Spectrometry Sales (Units) Growth Rate (2016-2027)
Figure 11. Global Clinical Mass Spectrometry Price Trends Growth Rate (2016-2027) (K USD/Unit)
Figure 12. Global Clinical Mass Spectrometry Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Clinical Mass Spectrometry Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Clinical Mass Spectrometry Sales (Units) Growth Rate (2016-2027)
Figure 16. Europe Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Clinical Mass Spectrometry Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Clinical Mass Spectrometry Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Clinical Mass Spectrometry Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Clinical Mass Spectrometry Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Clinical Mass Spectrometry Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Clinical Mass Spectrometry Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Clinical Mass Spectrometry Players Market Share by Revenue in Clinical Mass Spectrometry: 2016 & 2020
Figure 27. Clinical Mass Spectrometry Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Clinical Mass Spectrometry Revenue Share by Type (2016-2021)
Figure 29. Global Clinical Mass Spectrometry Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Clinical Mass Spectrometry Revenue Share by Application (2016-2021)
Figure 31. Global Clinical Mass Spectrometry Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Clinical Mass Spectrometry Sales Market Share by Type in 2020
Figure 33. North America Clinical Mass Spectrometry Sales Market Share by Application in 2020
Figure 34. Europe Clinical Mass Spectrometry Sales Market Share by Type in 2020
Figure 35. Europe Clinical Mass Spectrometry Sales Market Share by Application in 2020
Figure 36. China Clinical Mass Spectrometry Sales Market Share by Type in 2020
Figure 37. China Clinical Mass Spectrometry Sales Market Share by Application in 2020
Figure 38. Japan Clinical Mass Spectrometry Sales Market Share by Type in 2020
Figure 39. Japan Clinical Mass Spectrometry Sales Market Share by Application in 2020
Figure 40. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Type in 2020
Figure 41. Southeast Asia Clinical Mass Spectrometry Sales Market Share by Application in 2020
Figure 42. India Clinical Mass Spectrometry Sales Market Share by Type in 2020
Figure 43. India Clinical Mass Spectrometry Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Clinical Mass Spectrometry
Figure 46. Manufacturing Process Analysis of Clinical Mass Spectrometry
Figure 47. Clinical Mass Spectrometry Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
世界の質量分析キット市場規模・現状・予測（2021年-2027年） The mass spectrometry detection platform kit is based on triple quadrupole rod mass spectrometer for research and detection of target small molecules. At present, the main quantitative analysis and detection of target proteins, peptides and various small molecules and other indicators. The research …- ガスクロマトグラフィー（GC）＆ガスクロマトグラフィー質量分析（GC-MS）のグローバル市場2021 Gas chromatography (GC) is a common type of chromatography used in analytical chemistry for separating and analyzing compounds that can be vaporized without decomposition. China's market share of production is over 25%, ranking third in the world, and will continue to grow in the near future. Marke…
- 世界の臨床診断自動化市場規模・現状・予測（2021年-2027年） Clinical diagnosis automation is a part of the laboratory automation process which is a multi-disciplinary strategy for the purpose of capitalizing, optimizing, developing, and researching on the technologies used in clinical diagnosis. Market Analysis and Insights: Global Clinical Diagnosis Automat…
- 世界の臨床診断PCR市場規模・現状・予測（2021年-2027年） Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials. Market Analysis and Insights: Global Clinical Diagnostics PCR M…
- 世界の膀胱がん臨床試験市場規模・現状・予測（2021年-2027年） Bladder Cancer Clinical trials are research studies that involve people. The clinical trials on this list are for bladder cancer treatment. ... This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread from where it started to nearb…